Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-016587

Chief Legal Officer sold 102,780 shares at $12.04 ($1,237,471)

  • Chief Legal Officer acquired 138,632 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Barnes Alane P · Chief Legal Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-11 Exercise or conversion : show line 1 in the form +1,648 $4.73 $7,795 111,923 D
2021-05-11 Exercise or conversion : show line 2 in the form +33,132 $1.42 $47,047 145,055 D
2021-05-11 Exercise or conversion : show line 3 in the form +68,000 $5.45 $370,600 213,055 D
2021-05-11 Sale : show line 4 in the form −102,780 $12.04 $1,237,471 110,275 D
2021-05-12 Exercise or conversion : show line 5 in the form +35,852 $4.73 $169,580 146,127 D
Open-market sales · 102,780 sh · avg $12.04 · $1,237,471

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-05-11 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −1,648 35,852 D
2021-05-11 Exercise or conversion : show line 7 in the form Emp. Stock Option (Right to Buy) −33,132 0 D
2021-05-11 Exercise or conversion : show line 8 in the form Emp. Stock Option (Right to Buy) −68,000 0 D
2021-05-12 Exercise or conversion : show line 9 in the form Emp. Stock Option (Right to Buy) −35,852 0 D
Loading xslF345X03/form4.xml…